| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 05/25/2006 | US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases |
| 05/24/2006 | EP1658286A1 N-aryl-2-cyanooxazolidinones and their derivatives |
| 05/24/2006 | EP1658285A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 05/24/2006 | EP1658275A1 Crystalline form iv of linezolid |
| 05/24/2006 | EP1658273A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 05/24/2006 | EP1658263A1 Novel aminobenzophenone compounds |
| 05/24/2006 | EP1501812A4 Pna monomer and precursor |
| 05/24/2006 | CN1777577A Antibacterial agents |
| 05/24/2006 | CN1775774A Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues |
| 05/24/2006 | CN1775766A Method for preparing 2-trifluoro methyl benzoxazole |
| 05/23/2006 | US7049443 Such as 2-(3-(Acetyl(((5S)-3-(4-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-3 -fluorophenyl)-2-oxo-1,3-oxazolidin-5-yl)meth yl)amino)-1,1-dimethyl-3-oxopropyl)-3,5-dimethylphenyl dihydrogen phosphate; improved bioavailability |
| 05/23/2006 | US7049378 Polymerization of olefin |
| 05/23/2006 | CA2291134C Method for the preparation of citalopram |
| 05/18/2006 | WO2006051704A1 Imine compound |
| 05/18/2006 | WO2006051408A1 Oxazolidinone derivatives as antimicrobials |
| 05/18/2006 | WO2006037480A8 Hexafluoroisopropanol substituted ether derivatives |
| 05/18/2006 | US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type |
| 05/18/2006 | US20060106074 Er-b-selective ligands |
| 05/18/2006 | CA2587667A1 Imine compound |
| 05/17/2006 | EP1656370A2 Biaryl heterocyclic compounds and methods of making and using the same |
| 05/17/2006 | EP1656361A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 05/17/2006 | EP1656358A2 Stable polymorph of bifeprunox mesilate |
| 05/17/2006 | EP1656357A1 Oxazolidinone antibiotics and derivatives thereof |
| 05/17/2006 | EP1656348A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 05/17/2006 | EP1656342A2 Process for producing optically active beta-amino acid derivatives |
| 05/17/2006 | EP1246810B1 Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials |
| 05/16/2006 | US7045649 compounds are suitable, for example, for use as anorectics |
| 05/16/2006 | US7045539 Therapeutic benzoxazole compounds |
| 05/16/2006 | US7045518 Compounds for treatment of AIDS with enzyme inhibitors |
| 05/16/2006 | US7045516 Irritable bowel diosrders; gastrointestinal disorders; diarrhea |
| 05/16/2006 | CA2237752C Novel substituted aryl compounds useful as modulators of acetylcholine receptors |
| 05/11/2006 | US20060100283 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof |
| 05/11/2006 | US20060100258 Growth promotion method |
| 05/11/2006 | US20060100250 Biphenyl derivatives and their use as fungicides |
| 05/10/2006 | EP1655287A1 Probe for diseases with amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change |
| 05/10/2006 | EP1654259A1 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 05/10/2006 | EP1653952A2 Oxazole compounds for the treatment of neurodegenerative disorders |
| 05/10/2006 | EP1212296B9 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 05/10/2006 | CN1771236A Optical activity bisoxazoline compound, method for producing the same and use of the same |
| 05/10/2006 | CN1769275A Taxane derivatives and processes for the preparation thereof |
| 05/10/2006 | CN1255103C Diaryl cycloalkyl derivatives, the use thereof as PPAR activators and pharmaceutical compositions containing thereof |
| 05/09/2006 | US7041831 a [4-(5-phenyl)oxazolyl]-N-acetyl pyrrolidine or a [1-amino-2-hydroxy-2-phenylethyl]-N-acetyl pyrrolidine; enzyme inhibitors; anticarcinogenic, antitumor agents |
| 05/09/2006 | US7041692 Methods of treating factor VIIa-associated conditions with compounds having an amine nucleus |
| 05/09/2006 | US7041691 E.g., 2-(2,6-Dichloro-4-nitro-phenylsulfanyl)-benzothiazole-5-carboxylic acid methyl ester; modulators of peroxisome proliferator-activated receptors (PPARs) to treat type 11 diabetes and obesity; hypertension, hyperlipidemia, hypercholesterolemia, and hyperlipoproteinemia; antiinflammatory agents |
| 05/09/2006 | US7041690 Viricides; hepatitis virus infections |
| 05/09/2006 | US7041670 Florfenicol-type antibiotics |
| 05/04/2006 | WO2006047504A1 Aromatic amides as inhibitors of c-fms kinase |
| 05/04/2006 | WO2006046595A1 Optically active 4,4-disubstituted oxazolidine derivative and method for producing same |
| 05/04/2006 | US20060094887 Catalyst useful for various asymmetric synthesis reactions |
| 05/04/2006 | US20060094769 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 05/04/2006 | US20060094739 pharmaceutical drug for treating a fungal infection; controlling and preventing plant pathogenic microorganisms in agricultural crops |
| 05/04/2006 | US20060094721 Sulfonamides as potassium channel blockers |
| 05/04/2006 | US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 05/04/2006 | CA2584465A1 Heterocyclic carbonyl compounds and their use as sgk-inhibitors |
| 05/03/2006 | EP1652843A1 Amide derivatives |
| 05/03/2006 | EP1652839A2 Drug efflux pump inhibitor |
| 05/03/2006 | EP1651642A1 Pna monomer and precursor |
| 05/03/2006 | EP1651231A2 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
| 05/03/2006 | EP1495007A4 Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | EP1153017B1 Bicyclic compounds and their use as integrin receptor ligands |
| 05/02/2006 | USRE39088 Amide compounds and use of the same |
| 05/02/2006 | US7038058 Continuous preparation of substituted oxazoles |
| 05/02/2006 | US7037930 3-arylphenyl sulfide derivative and insecticide and miticide |
| 05/02/2006 | US7037927 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 05/02/2006 | US7037914 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient |
| 05/02/2006 | CA2250426C Amidinohydrazones as protease inhibitors |
| 05/02/2006 | CA2174544C Method for using pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenyl-amino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines as adrenergic agents |
| 04/27/2006 | WO2006045088A2 Polymer-filler coupling additives |
| 04/27/2006 | WO2006044961A1 Ppar-gamma modulatores |
| 04/27/2006 | WO2006044415A2 Carboxylic acid peri - substituted bicyclics for occlusive artery disease |
| 04/27/2006 | WO2006044000A1 Sulfonamide pert-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | US20060089366 New piperazine and piperidine compounds |
| 04/27/2006 | US20060089365 Heterocyclic compounds useful as nurr-1 activators |
| 04/27/2006 | US20060089357 Novel compounds and compositions as cathepsin inhibitors |
| 04/27/2006 | DE102004051277A1 Heterocyclische Carbonylverbindungen Heterocyclic carbonyl |
| 04/27/2006 | CA2583828A1 Carboxylic acid peri-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | CA2583667A1 Sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 04/26/2006 | EP1648876A1 5-ht sb 2b /sb receptor antagonists |
| 04/26/2006 | CN1764454A Cyclic protein tyrosine kinase inhibitors |
| 04/26/2006 | CN1763018A Oxazolidinone analog compound |
| 04/26/2006 | CN1253458C Process for preparing substance GM-95 |
| 04/26/2006 | CN1253436C Large conjugated half cyanine dye, its synthesis and its sensitized nano-crystal semiconductor solar energy battery |
| 04/25/2006 | US7034043 Cell adhesion inhibitors |
| 04/25/2006 | US7034025 Administering to a mammal an effective dose of a cysteine derivatives containing heteroaromatic group for the treatment of arterial tension, embryogenesis, oncogenesis, diabetes, cell proliferation, and other diseases |
| 04/25/2006 | US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors |
| 04/20/2006 | WO2005096734A3 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators |
| 04/20/2006 | WO2005030705A9 Inhibitors of histone deacetylase |
| 04/20/2006 | US20060084730 Having oxazole, thiazole, tri(alkoxy)silanes or triallyltin moieties connected by an arylene or alkylene linker moiety to a dipolar nitrone, nitrile oxide or nitrilimine moiety; rubbers with reduced hysteresis; tires |
| 04/20/2006 | US20060084702 (2S)-2-ethylphenylpropionic acid derivative |
| 04/20/2006 | US20060084680 ((1S)-5-{2-[(3-methyl-7-propyl-1,2-benzisoxazol-6-yl)oxy]ethoxy}-2,3-dihydro-1H-inden-1-yl)acetic acid; diabetes, obesity, hyperlipidemia, and atherosclerotic diseases; hyperglycemia, hyperinsulinemia, impaired glucose tolerance, dyslipidemia, hypertriglyceridemia, and insulin resistance |
| 04/20/2006 | US20060084663 Alkanoic acids, nitriles and amides substituted with a group containing benzene ring linked through a thiazolyl- or oxazolyl- phenyl group; e.g., {4-[4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-2-propyl-phenoxy}-acetic acid; treating diabetes and atherosclerosis |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/20/2006 | US20060084657 Piperazine derivative |
| 04/19/2006 | EP1646629A2 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 04/19/2006 | EP1646617A2 Sulfonamide compounds and methods of making and using the same |
| 04/19/2006 | EP1423363B1 Oral antidiabetic agents |
| 04/19/2006 | EP1204650B1 Substituted 2-arylbenzazole compounds and their use as antitumour agents |
| 04/19/2006 | EP1177176B1 Tri-aryl acid derivatives as ppar receptor ligands |
| 04/19/2006 | CN1761650A Compounds, a process for their preparation and their use as dyes and pigments |